Acquisition Signal Recent acquisition of ILS Automation by DCI, Inc. (October 2025) suggests potential strategic shifts, integration opportunities, and expanded service capabilities that could create cross-sell of control system integration, SCADA, and bioprocess automation expertise.

Bioprocess Focus Specialization in AFC bioreactor control systems and cell-culture/fermentation processes positions ILS to win more life sciences contracts, including biotech manufacturing facilities seeking robust real-time control, data integration, and compliant automation solutions.

Ignition Ecosystem Award recognition at the Ignition Community Conference and expertise in Ignition SCADA development indicate strong alignment with customers using Inductive Automation platforms, opening doors for more SCADA integration projects and custom module work.

Lifecycle Solutions End-to-end offerings from control panel fabrication and electrical design to software integration and database connections present opportunities to upsell full lifecycle projects, including commissioning, validation, and ongoing support.

SMB to Niche Growth Annual revenue in the low-to-mid multi-million range with a small team (2-10 employees) suggests potential for scalable partnerships with larger systems integrators or tools that enable efficient remote services, training, and modular automation solutions for mid-market process industries.